


| New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia |
|
IC 265 is being developed for dry eye. Dry eye is a large and growing problem in China due to several factors including a lack of approved drugs for the condition, an aging population, and prolonged screen viewing. In the United States , an estimated 80% of patients with moderate to severe dry eye are not on a prescription medication.
Posted: 2020-07-28 15:03:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.